RNR — RenaissanceRe Holdings Ltd. Stock Price, Chart & AI Report

Neutral Apr 14, 2026 • 20:15 UTC Investing.com • Peter Frank

A Quiet Outperformer With a Catastrophe Caveat

Axis Capital, a specialty insurer and reinsurer, delivered strong 2025 results with record premiums, record underwriting income, and a 19.4% annualized return on equity. The company's shift toward higher-margin specialty insurance lines is paying off, with the insurance segment now representing 74% of business. However, investors should be cautious as the stock has already had a significant run-up, and the company faces inherent risks from catastrophic events and competitive pressures that could erode margins.

AXS AXSPE RNR RNRPF specialty insurance reinsurance underwriting income combined ratio

Sentiment note

Mentioned as a competitor to Axis Capital in the specialty insurance and reinsurance space, but no specific performance data or sentiment indicators provided in the article.

Positive Oct 16, 2024 • 10:00 UTC GlobeNewswire Inc. • N/A

VedTechBio® Launches RxAgentAI™ – an Artificial Intelligence and Machine Learning Platform, catering to the decision making and strategic needs of stakeholders in the life sciences industry AND VedTechBio® Announces a Drug Discovery Collaboration with RenaissThera®

VedTechBio, a biopharma-tech company, has launched RxAgentAI, an AI and ML platform for the life sciences industry. It has also announced a drug discovery collaboration with RenaissThera, a biotech company working on metabolic diseases.

RNR RNRPF RNRPG AI machine learning drug discovery biopharma metabolic diseases

Sentiment note

RenaissThera is a biotech company focused on developing novel treatments for metabolic diseases, and has partnered with VedTechBio to leverage their AI and computational capabilities, suggesting the company's commitment to innovation and collaboration.

Unknown Jun 27, 2024 • 18:27 UTC Zacks Investment Research • Zacks Equity Research

Here's Why You Should Hold RenaissanceRe (RNR) Stock for Now

RenaissanceRe (RNR) is expected to benefit from rising premiums, net investment income, and underwriting capabilities.

RNR BRO AMBC ROOT

Unknown Jun 13, 2024 • 14:55 UTC Zacks Investment Research • Zacks Equity Research

W.R. Berkley (WRB) Boosts Shareholders' Value Via Several Moves

Improved pricing, expansion of international business, reserving discipline, a solid balance sheet and a prudent capital management policy should help W.R. Berkley (WRB) maintain its streak of dividend hikes and special dividends.

WRB RNR AXS RDN

Unknown Jun 13, 2024 • 10:20 UTC Zacks Investment Research • Zacks Equity Research

Is First Trust Financials AlphaDEX ETF (FXO) a Strong ETF Right Now?

Smart Beta ETF report for FXO

FXO RNR PGR AGO

Unknown May 30, 2024 • 15:31 UTC Zacks Investment Research • Zacks Equity Research

RenaissanceRe (RNR) Up 2% Since Last Earnings Report: Can It Continue?

RenaissanceRe (RNR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

RNR FAF

Unknown May 30, 2024 • 12:06 UTC Zacks Investment Research • Zacks Equity Research

Garmin and O-I Glass have been highlighted as Zacks Bull and Bear of the Day

Garmin and O-I Glass are part of the Zacks Bull and Bear of the Day article.

OI GRMN RNR AXS

Unknown May 29, 2024 • 15:58 UTC Zacks Investment Research • Tanuka De

3 Insurance Stocks to Watch on Share Buyback Spree

We focus on AXS, RDN and RNR whose board of directors recently approved new share buyback programs, banking on the confidence that the companies' operational expertise will boost liquidity.

RNR AXS RDN

Unknown May 10, 2024 • 15:40 UTC Zacks Investment Research • Zacks Equity Research

RNR vs. CINF: Which Stock Is the Better Value Option?

RNR CINF

Unknown May 8, 2024 • 16:00 UTC Zacks Investment Research • Zacks Equity Research

RenaissanceRe (RNR) Moves to Buy: Rationale Behind the Upgrade

RenaissanceRe (RNR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

RNR

Unknown May 1, 2024 • 17:23 UTC Zacks Investment Research • Zacks Equity Research

RenaissanceRe (RNR) Q1 Earnings Beat on Solid Property Segment

RenaissanceRe's (RNR) first-quarter results reflect a solid underwriting performance and improved investment income. A rise in expenses partially offsets its quarterly results.

RLI CB WRB RNR

Unknown Apr 30, 2024 • 23:00 UTC Zacks Investment Research • Zacks Equity Research

Here's What Key Metrics Tell Us About RenaissanceRe (RNR) Q1 Earnings

Although the revenue and EPS for RenaissanceRe (RNR) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

RNR